In mid-July, shares of BEAT tanked after the Company withdrew its 2009 financial outlook following a major cut in the reimbursement rate by Pennsylvania Medicare carrier Highmark for the Company's mobile cardiac outpatient telemetry (MCOT) services. As of 9/1/09, Highmark's reimbursement rate for MCOT services will decrease to $754, compared to the previous rate of $1,123 per service.

CardioNet's MCOT is an ambulatory cardiac monitoring service that analyzes patients' heartbeats on a real-time basis and includes automatic arrhythmia detection and wireless ECG transmission. The technology benefits both patients and physicians by providing 24/7 monitoring throughout the year on a remote basis to aid in the correct diagnosis and treatment of arrhythmias that may otherwise not be detected through Holter monitors or other instruments.

Predictably, BEAT received a wave of downgrades from analysts given the uncertainties surrounding the Company's profitability and the prospect of reimbursement cuts from other third-party payers. Despite these uncertainties, BEAT trades at an enterprise value of about 100 million and a significant discount to other companies in the Health IT industry in terms of PBR and PSR with many of the companies trading at ratios above 3X for these parameters.

My Global Health IT Index tracks the performance of 65 companies which derive the majority of their revenue from the following activities: (1) the electronic transmission, storage, and processing of prescriptions (e-prescribing); (2) electronic storage and systems for healthcare facility operations and medical records; and (3) electronic systems, devices, and services for remote, real-time monitoring of patient health parameters (telemedicine).

Despite uncertainties over the prospects for major healthcare reform, increased spending on Health IT is widely recognized as an important feature to modernize medical records, measure healthcare outcomes, and improve/extend the reach of modern healthcare technology through remote patient monitoring and other related technologies.

The Health IT index has easily outpaced the overall market on a year-to-date basis (YTD), including some top YTD stock price gainers from the index such as Allscripts-Misys (NASDAQ:MDRX) (+61%) (PBR = 3.4, PSR = 4.3), Eclipsys (NASDAQ:ECLP) (+27%) (PBR = 2.5, PSR = 1.9), Cerner (NASDAQ:CERN) (+68%) (PBR = 3.9, PSR = 3.2), Computer Programs & Systems (NASDAQ:CPSI) (+38%) (PBR = 9.5, PSR = 3.3), Quality Systems (NASDAQ:QSII) (+27%) (PBR = 10, PSR = 6.4), and Merge Healthcare (NASDAQ:MRGE) (+191%) (PBR = 17, PSR = 3.6).

Despite the uncertainties surrounding the reimbursement cuts for the Company's MCOT service and its murky financial outlook for 2009, I own shares of BEAT due to its strong balance sheet, extremely oversold stock price, the long-term potential for either a return to earnings growth or an acquisition by a larger player in the Health IT industry, and overall favorable market conditions for the healthcare sector as large-scale reform is unlikely to occur with the trend of consolidation expected to continue.

I think a buyout of BEAT is most likely to occur from a larger player in the Health IT industry such as Philips (NYSE:PHG) or GE Healthcare (NYSE:GE) because of the following factors: (1) BEAT offers a specialized service for ambulatory monitoring of heart rhythms for the diagnosis of arrhythmias; (2) BEAT has an enterprise value of just $100 million, including $50 million in net cash as part of a strong balance sheet; and (3) a larger player in the industry is better able to absorb the reimbursement cuts since BEAT's MCOT offering would merely expand the acquiring company's product offerings.

Two other small-cap companies that I previously owned in the Health IT space include VisICU and Sunquest Information Systems, which were acquired by Philips (NYSE:PHG) and Misys (now MDRX). VisICU is most analogous to BEAT since it was acquired in early 2008 in less than two years from the Company's IPO during spring 2006. VisICU provided a specialized Health IT service that allowed for remote monitoring of patients in intensive care units (eICU) and also experienced a quick run-up in its share price following the Company's IPO, only to come crashing down into single digits before Philips acquired the company for $12/share or about $430 million in February 2008.

Disclosure: Long BEAT

"Computer Programs & Systems (NASDAQ: CPSI), a health care information solutions company, has been pushing up against a 52-week high during the past few days," notes Alex Kolb. 

In Zacks Elite Stock of the Day, he explains, "The company has stellar fundamentals that make this a great growth and income pick."

"The company provides healthcare information solutions for community hospitals with over 650 client hospitals in 46 states.

"The company was founded in 1979, and is a single-source vendor providing comprehensive software and hardware products as well as complete installation services and extensive support.

"CPSI's fully integrated, enterprise-wide system automates clinical and financial data management in each of the primary functional areas of a hospital.

"Its 700 technical, healthcare and medical professionals provide system implementation and continuing support services as part of a comprehensive program designed to respond to clients' information needs in a constantly changing healthcare environment.

"The company recently posted fourth-quarter results. For the year, total revenues jumped 8.8% to $119.7 million from the previous year's $110.0 million. Full-year net income increased 19.5% year-over-year to $15.4 million, or $1.43 per share, compared with $12.9 million, or $1.20 per share. 

"Some of the stellar fundamentals that make CPSI a great growth and income pick include the company's return on equity (ROE) of 40%, which soars past the industry average of 9%. It has a solid balance sheet with no debt. The company's net profit margin of 13% also tops the industry average of 5%. 

"The company recently posted fourth-quarter results. For the year, total revenues jumped 8.8% to $119.7 million from the previous year's $110.0 million. Full-year net income increased 19.5% year-over-year to $15.4 million, or $1.43 per share, compared with $12.9 million, or $1.20 per share.

"The shares have been soaring as analysts hike earnings estimates. Wall Street sees earnings growth of 12% in 2009 and 15% in 2010.  The company also declared a quarterly cash dividend of 36 cents per share, which was paid out on February 26. 

"CPSI is taking care of shareholders with a dividend yield of 4.8%, which is high above the industry average as most of the company's peers pay no dividend.

"Management noted that CPSI has been in business for almost three decades and has proven that it can continue fulfilling and exceeding the expectations of its customers shareholders, regardless of national economic cycles."